New hope for kids with Arthritis-Related eye disease
NCT ID NCT01385826
Summary
This trial tested whether the drug adalimumab could reduce painful eye inflammation (uveitis) in children with juvenile arthritis. The study involved 34 children whose eye inflammation did not improve with standard steroid drops and methotrexate. For the first two months, half received adalimumab injections and half received placebo injections, then all children could receive adalimumab for up to a year to assess longer-term effects and safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UVEITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital of necker Enfants malades
Paris, 75015, France
Conditions
Explore the condition pages connected to this study.